Clinical Trial Update: Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on allogeneic hematopoietic stem cell transplantation for multiple myeloma, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Allogeneic hematopoietic stem cell transplantation

Snippet

Sponsor: Hackensack Meridian Health | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2022-05-25